Website & contact details
- Group website
- The site of this company’s group or brand.
Bioscript Midco 2 Limited
- Incorporated
- 19 February 2021 (5 years)
- Previously known as
- Libretto Midco 2 Limited (until 29 October 2021)
- Industry
- Activities of other holding companies n.e.c. (64209)
- Directors
- Owned by
- Bioscript Midco 1 Limited
- Accounts type
- Full
- Region
- North West
- Address
- Suite AGreenway House Larkwood WayTytherington Business ParkMacclesfieldSK10 2XR
Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 6 February 2027
- Last conf. stmt
- 23 January 2026
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 15 February 2024
British
Born December 1984 (41)
Director · Appointed 2 May 2023
British
Born September 1973 (53)
Officer history (4 former)
19 April 2024
15 February 2024
14 July 2023
2 May 2023
7 July 2021
7 July 2021
7 July 2021
7 July 2021
19 February 2021
19 February 2021
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Bioscript Midco 1 Limited
Corporate entity · Notified 19 February 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited
Group structure 13 shown
Ownership group derived from the Companies House PSC register
Bioscript Midco 2 Limited This company
Bioscript Limited Owns 75–100% of shares
Azimuth Pharma Limited Owns 75–100% of shares
Fortis Pharma Consulting Limited Owns 75–100% of shares
Bioscript Group Limited Owns 75–100% of shares
Bioscript Stirling Limited Owns 75–100% of shares
Medologie Limited Owns 75–100% of shares
Enzyme Communications Ltd Owns 75–100% of shares
Meridian Healthcomms Holdings Limited Owns 75–100% of shares
Cancer Communications and Consultancy Limited Owns 75–100% of shares
Meridian Healthcomms Limited Owns 75–100% of shares
Triducive Partners Limited Owns 75–100% of shares
Valid Insight Ltd Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 30 September 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £8,067,326
- Profit Before Tax
- £0
- Debt Ratio
- 86%
- Current Ratio
- 1.0x
- Return on Equity
- 0%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Fixed Assets | £8,072,087 | £7,172,087 | £7,156,728 | £2,824,058 |
| Current Assets | £48,059,920 | £44,146,534 | £37,203,541 | £29,659,379 |
| Creditors (< 1 year) | £48,064,681 | £44,151,295 | £37,208,302 | £29,664,140 |
| Net Current Assets | (£4,761) | (£4,761) | (£4,761) | (£4,761) |
| Net Assets | £8,067,326 | £7,167,326 | £7,151,967 | £2,819,297 |
| Shareholder Funds | £8,067,326 | £7,167,326 | £7,151,967 | £2,819,297 |
Filings 37
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 June 2026 | Full accounts | 30 September 2025 | ||
| 1 May 2026 | Registration of a charge | |||
| 5 February 2026 | Confirmation statement with no updates | 23 January 2026 | ||
| 27 June 2025 | Full accounts | 30 September 2024 | ||
| 7 February 2025 | Director's details changed |
Some other companies at this address
Other companies in this industry
London
Chigwell
Carnforth
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →